| Document |
Document Title |
|
WO/2006/035010A1 |
The use of 4-isoamylcyclohexanol [4-(3-methylbutyl)cyclohexan-1-ol], in particular, cis 4-isoamylcyclohexanol, as odiferant or flavouring, in particular, as floral odiferant characterised by rose and geranium notes, is disclosed. The inv...
|
|
WO/2006/028297A1 |
A water-soluble fullerene characterized by being at least one hydroxylated fullerene comprising a fullerene core and, bonded thereto, over 30 hydroxyls (OH), which water-soluble fullerene exhibits a desirable water solubility, having a h...
|
|
WO/2006/023333A1 |
A cyclic ketone/alcohol mixture is prepared by catalytic oxidation of the corresponding cycloalkane or catalytic decomposition of the corresponding cycloalkyl hydroperoxide. Gold supported on a porous crystalline silicate containing less...
|
|
WO/2006/019483A1 |
The present invention relates a composition having a high content of xanthophyll esters, where the xanthophyll ester component of the composition of a high proportion of trans-lutein esters. The present invention also provides methods of...
|
|
WO/2006/016912A2 |
The present invention provides convergent processes for preparing (-)-beta-elemene, (-)-beta-elemenal, (-)-beta-elemenol, and (-)-beta-elemene fluoride and analogues thereof. Also provided are intermediates useful for preparing (-)-beta-...
|
|
WO/2006/006413A1 |
Disclosed is a method for producing 2-adamantanol and 2-adamantanone from 1-adamantanol wherein at least one acid catalyst selected from Lewis acids and solid acids is used as a catalyst in combination with at least one selected from the...
|
|
WO/2006/004669A1 |
The present invention provides a method of making fulvenes, particularly 6-aryl-6-alkylfulvenes, 6-aryl-6-alkenylfulvenes, and related compounds, by combining alkyl- or alkenyl-arylketones with magnesium cyclopentadienyl reagents in nonp...
|
|
WO/2006/001398A1 |
Disclosed is a method for producing polyhalogenated diamantanes which is characterized by reacting diamantanes with a halosulfonic acid. Also disclosed is a method for producing diamantane polyols which is characterized in that the polyh...
|
|
WO/2005/123653A1 |
An adamantane derivative which can be a raw material compound for a polymer having excellent etching resistance and improved transparency to light of short wavelengths is produced from easily available raw materials by an economically ad...
|
|
WO/2005/121058A1 |
The invention concerns a 3-alkylated crystallized (1 R,4S)-p-menthan-(3)-ol derivative, of formula A or B, wherein: either when R2 represents hydrogen or a methyl radical, R1 represents a -(CH2)n-OH where n can be 1, 2 and 3, or when R2 ...
|
|
WO/2005/113473A2 |
The present invention relates to a process for making indenol esters or ether from an &agr -substituted cinnamic aldehyde derivative such as an acetal or an acylal. Said reaction is promoted by the use of strong mineral acids, sulphonic ...
|
|
WO/2005/112915A2 |
The present invention provides compositions, methods, and kits for reducing oxidative stress thereby extending life span. The compositions, methods, and kits of the present invention can also be used to treat diseases of aging resulting ...
|
|
WO/2005/105716A1 |
Disclosed is a method for producing a cycloalkanol and/or a cycloalkanone by oxidizing a cycloalkane with a molecular oxygen in the presence of a compound represented by the following formula (1). (1) (In the formula, X1-X8 respectively ...
|
|
WO/2005/097717A1 |
A process for producing an alcohol and a ketone, i.e., 2-adamantanol and 2-adamantanone, from adamantane and molecular oxygen, characterized by oxidizing the adamantane in the presence of a catalyst system containing one or more elements...
|
|
WO/2005/092825A1 |
Optically active alcohols are produced by adding a ruthenium complex represented by the following formula (I), RuCl[(S,S)-Tsdpen](p-cymene), and a ketone to a polar solvent and mixing the resulting system in the presence of pressurized h...
|
|
WO/2005/085159A1 |
Inositol derivatives in accordance with the present invention are effective in significantly enhancing the transportation of various therapeutic molecules across a biological membrane, which may include the plasma membrane, nuclear membr...
|
|
WO/2005/080304A1 |
Disclosed is an organic semiconductor material which exhibits a high mobility and is excellent in solubility in solvents and oxidation resistance. Also disclosed are an organic semiconductor thin film having a high mobility and an organi...
|
|
WO/2005/070860A1 |
The present invention relates to substituted bicyclo[3.3.1]nonanes and bicyclo[3.3.1]nonenes of formula (I) wherein R, and R1 to R5 have the same meaning as described in the specification.
|
|
WO/2005/070856A1 |
An octahydronaphthalene derivative having ICAM-I manifestation inhibitory activity or a pharmaceutically acceptable salt of the derivative. Also provided is, for example, an ICAM-1 manifestation inhibitor, inflammatory disease remedy, im...
|
|
WO/2005/068409A1 |
The present invention relates to a process for obtaining stabilized Lutein with about 95% yield from oleoresin at ambient temperature, said process comprising steps of dissolving cleaned oleoresin in alcohol to obtain dissolved Xanthophy...
|
|
WO/2005/049538A1 |
In solid polymer fuel cells, a material resulting from chemical modification of a hollow fullerene of C60, etc. with a proton dissociable group has conventionally be used as a material for an electrolyte membrane capable of conducting pr...
|
|
WO/2005/036265A2 |
Novel positive-working photoresist compositions are disclosed. The monomers of the base resin of the resist contain diamondoid-containing pendant groups higher than adamantane in the polymantane series; for example, diamantane, triamanta...
|
|
WO/2005/031461A1 |
The invention pertains to low polydispersity acrylic polymers useful for photoimaging and photoresist compositions, and to the photoimaging processes which use these compositions. The low polydispersity polymers of this invention are pre...
|
|
WO/2005/023831A1 |
The invention relates to detection of cholesterol ozonation products that are generated by atherosclerotic plaque material, and to methods of detecting vascular conditions that relate to the accumulation and oxidation of cholesterol.
|
|
WO/2005/016901A1 |
A compound 4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-2,2-dimethylpiperazi
ne and salts thereof, pharmaceutical compositions comprising the compound and salts, and medical use thereof, including for treatment of schizophrenia and other psyc...
|
|
WO/2005/016900A1 |
4-((1R,3S)-6-Chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiper
azine hydrogen succinate or hadrogen malonat, pharmaceutical compositions containing these salts and the medical use thereof, including for the treatment of schizophrenia and o...
|
|
WO/2004/098612A2 |
The present invention relates to a method of treating mast cells associated diseases comprising administrating calcitriol or analogs thereof to a mammal in need of such treatment. It is also aimed at new analogs and to the combined use o...
|
|
WO/2004/094350A1 |
The present invention provides a method for extracting carotenoids from green plant materials using supercritical fluid extraction. A first and second supercritical fluid extraction is performed on the green plant composition at two diff...
|
|
WO/2004/094352A1 |
A novel method for industrially advantageously hydrogenating a phenol. The method of phenol hydrogenation comprises subjecting a phenol to a hydrogenation reaction in the presence of carbon dioxide which participates in the reaction, and...
|
|
WO/2004/092100A1 |
Compounds of formula (Ia): wherein R1, R2, R3, R4a, R4b, R5 and R6 are defined herein, as well as other indene derivatives are disclosed herein. Pharmaceutical compositions containing the compounds and methods of using the compounds are ...
|
|
WO/2004/078688A1 |
A novel alicyclic unsaturated compound represented by the general formula (1): wherein at least one of R1 and R2 is a fluorine atom or a fluorinated alkyl group; a polymer formed by the polymerization of a polymer precursor comprising th...
|
|
WO/2004/069778A1 |
The present invention relates to a novel class of antimicrobial compounds. These trinervitane compounds can be used for a variety of purposes such as for the treatment of microbial infections and diseases, and as disinfectant agents.
|
|
WO/2004/052832A1 |
The invention provides novel compounds useful in the production of fluorinated adamantane derivatives which are excellent in etching resistance and useful as photolithographic material and so on, that is, compounds represented by the gen...
|
|
WO/2004/041760A2 |
Provided are compounds described by the formula (I), wherein W, X, Y and Z are independently selected from the group consisting of hydrogen, fluorine, hydroxyl, substituted alkyl and unsubstituted alkyl. Also provided are methods of maki...
|
|
WO/2004/039991A2 |
A method is described for preparing astaxanthin esters from zeaxanthin by acylation of zeaxanthin with an acylating agent followed by contacting the esterified zeaxanthin with an oxidizing agent to produce esterified astaxanthin. The ast...
|
|
WO/2004/024657A2 |
Disclosed herein is a process for the production of a mixture of cyclohexanone and cyclohexanol by oxidation of cyclohexane and decomposition of cyclohexyl hydroperoxide.
|
|
WO2004010512A9 |
Novel heterodiamondoids are disclosed. These heterodiamondoids are diamondoids that include heteroatoms in the diamond lattice structure. The heteroatoms may be either electron donating, such that an n-type heterodiamondoid is created, o...
|
|
WO/2004/020083A1 |
The invention relates to a method for oxidising an educt using an oxidant in order to obtain a product. Said method is characterised in that the oxidation is carried out in a reaction device (1) comprising a sump region at the lower end,...
|
|
WO/2004/018417A1 |
The invention disclosed in this application relates to a process for the preparation of xanthophyll crystals containing at least not less than 85 % total xanthophylls with at least 90 % trans-lutein and / or zeaxanthin, trace amounts of ...
|
|
WO/2004/016576A1 |
A compound represented by the general formula (I) [wherein ring A represents an optionally substituted 5- to 8-membered ring; ring B represents a further optionally substituted 4- to 10-membered ring; ring C represents a further optional...
|
|
WO/2004/013149A1 |
Group 4 metal constrained geometry complexes comprising tricyclic 4-arylsubstituted indenyl ligands, especially 1,5,6,7-tetrahydro-4-aryl-s-indacen-1-yl ligands, catalytic derivatives thereof, processes for preparing the same and their...
|
|
WO/2004/005229A1 |
The present invention provides compounds of the formula wherein A is of the formula and X, Y, n, R1-R25 are as described in the specification which are modulators of the glucocorticoid receptor and are thus useful for the treatment of an...
|
|
WO/2004/000776A1 |
Novel compounds of formula (I) and their use in flavour and fragrance compositions. R1 to R13 have the meaning as described in the specification.
|
|
WO/2003/104169A2 |
Disclosed is a process for cyclohexyl hydroperoxide (CHHP) decomposition using in aqueous alkaline solution in presence of cobalt catalyst.
|
|
WO/2003/101924A1 |
The invention relates to menthol pressed articles, to a method for the producing menthol pressed articles and to the use thereof.
|
|
WO2003011805B1 |
The invention relates to the hydrated compound of an unsaturated monoterpenoid and to the use thereof, preferably in conjunction with a C6-C13-carboxylic acid, as insect repellent.
|
|
WO/2003/080553A1 |
The invention relates to substituted cyclopentene derivatives, to a method for the production thereof and to the use of the same for producing pharmaceuticals which are especially used to treat and/or prevent thromboembolic diseases.
|
|
WO/2003/076375A1 |
The invention provides compounds represented by the general formula: [wherein X is selected from the group consisting of hydroxyl, substituted hydroxyl, halogeno, mercapto and substituted mercapto; one of Y1 and Y2 is hydrogen or alkyl a...
|
|
WO/2003/074453A1 |
A method for the production of cyclohexanol from benzole by a) production of cyclohexene by hydrogenation of benzole in the presence of a catalyst and b) production of cyclohexanol by hydratation of cyclohexene in the presence of a catal...
|
|
WO/2003/066524A1 |
A metallized mesoporous silicate which is obtained by (i) reacting (a) either a metal peroxide obtained by the reaction of an aqueous hydrogen peroxide solution with at least one metal or metal compound selected from the group consisting...
|
